Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Glaukos Corporation
• Treatments: Maleic acid; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol; Travoprost

Criteria

Inclusion Criteria:

• Open angle glaucoma

Exclusion Criteria:

• Uveitic, neovascular, or angle closure glaucoma; or glaucoma associated with vascular disorders.

• Functionally significant visual field loss, including severe nerve fiber bundle defects.

• Prior glaucoma surgery.

• Uncontrolled systemic disease, pregnant females or those planning a pregnancy.

• Other ocular status conditions, etc.